A Aralex Aachen research explorer

Harini P. Kothari Sign in to save

OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

0

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (2)

2× Galapagos, Inc., Princeton, NJ, USA
1× 14Galapagos, Inc., Princeton, United States

Papers 3 stored

All · Aachen affiliation only

High complete response rates, low dropout rate, and low-grade toxicities in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) receiving GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 DLBCL cohort
2025 Blood conference-abstract Medicine CAR-T cell therapy research

2

citations
CT-945: Low Rates of High-Grade Toxicities With GLPG5101, a Fresh, Stem-Like, Early Memory Phenotype Anti-CD19 CAR T-Cell Therapy, in Patients With Non-Hodgkin Lymphoma in the ATALANTA-1 Study
2025 Clinical Lymphoma Myeloma & Leukemia conference-abstract Medicine CAR-T cell therapy research

0

citations
POSTER: CT-945 Low Rates of High-Grade Toxicities With GLPG5101, a Fresh, Stem-Like, Early Memory Phenotype Anti-CD19 CAR T-Cell Therapy, in Patients With Non-Hodgkin Lymphoma in the ATALANTA-1 Study
2025 Clinical Lymphoma Myeloma & Leukemia article Medicine CAR-T cell therapy research

0

citations

3 results